Researchers investigate possible colon cancer risk for new generation of weight-loss drugs

3 marzo 2015

Gastric bypass and similar stomach-shrinking surgeries are a popular option for obese patients looking to lose weight or treat type 2 diabetes. While the surgeries have been linked to a decreased risk in many cancers, the single outlier is colon cancer. Scientists now present work in mice that could explain this association and raise safety concerns for a new generation of weight-loss drugs that mimic the biological after effects of these procedures.